FAP and cancer: This study aimed to establish the spectrum of FAP expression across various cancers by immunohistochemistry and to explore whether 68Ga FAP inhibitor (FAPi)–46 PET biodistribution faithfully reflects FAP expression from resected cancer and non-cancer specimens.